KZR Stock Price History and Quote Analysis Insights for Investors
Kezar Life Sciences, Inc.
Stock Price Today
Kezar Life Sciences, Inc. (KZR) stock declined over -0.44%, trading at $6.75 on NASDAQ, down from the previous close of $6.78. The stock opened at $6.79, fluctuating between $6.72 and $6.96 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
South San Francisco, CA 94080
United States
Website: https://www.kezarlifesciences.comContact: 650 822 5600About Company
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b clinical trials in systemic lupus erythematosus and lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of KZR-261; and KZR-TBD for the treatment of oncology and immunology. The company was incorporated in 2015 and is based in South San Francisco, California.
Company Information
| Employees | 58 |
| Beta | 0.22 |
| Sales or Revenue | $7.00M |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Kezar Life Sciences, Inc. (NASDAQ: KZR) stock price is $6.75 in the last trading session. During the trading session, KZR stock reached the peak price of $6.96 while $6.72 was the lowest point it dropped to. The percentage change in KZR stock occurred in the recent session was -0.44% while the dollar amount for the price change in KZR stock was -$0.03.
The NASDAQ listed KZR is part of Biotechnology industry that operates in the broader Healthcare sector. Kezar Life Sciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Pattie Chiang
Vice President & Corporation Controller
Dr. Kieron Wesson Ph.D.
Senior Vice President of CMC & Supply Chain
Mr. Zung To
Senior Vice President of Clinical Devel. Operations
Dr. Neel K. Anand Ph.D.
Vice President of Medicinal Chemistry & Head of Drug Discovery
Dr. Christopher J. Kirk Ph.D.
Co-Founder, Pres, Chief Scientific Officer & Director
Dr. Nick Mordwinkin Ph.D., Pharm.D.
Chief Bus. Officer
Dr. Jack Taunton Ph.D.
Co-Founder
Dr. Noreen Roth Henig M.D.
Chief Medical Officer
Ms. Gitanjali Jain
Vice President of Investor Relations & External Affairs
Mr. Marc L. Belsky
Chief Financial Officer & Sec.
Mr. Mark Schiller
Senior Vice President of Legal Affairs
Mr. Michael Wolfe
Senior Vice President of Fin. & Bus. Operations
Mr. John Franklin Fowler
Co-Founder, Chief Executive Officer & Director
KZR's closing price is 29.81% higher than its 52-week low of $5.20 where as its distance from 52-week high of $11.40 is -40.79%.
Number of KZR employees currently stands at 58.
Official Website of KZR is: https://www.kezarlifesciences.com
KZR could be contacted at phone 650 822 5600 and can also be accessed through its website. KZR operates from 4000 Shoreline Court, South San Francisco, CA 94080, United States.
KZR stock volume for the day was 28.58K shares. The average number of KZR shares traded daily for last 3 months was 106.19K.
The market value of KZR currently stands at $49.25M with its latest stock price at $6.75 and 7.3M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com